Skip to content
Search

Latest Stories

Anosmia added to COVID-19 symptom list

The United Kingdom has added the loss of smell and taste to its official list of COVID-19 symptoms including fever and new continuous cough - a step that it hopes could help pick up about 2 per cent more cases of novel coronavirus.

The change, announced by Professor Jonathan Van-Tam, England's deputy chief medical officer, came after scientists advising the government decided it could help pick up more cases if included in the basic case definition.


"Our basic case definition, which has for some time been new continuous cough or fever, will change to new continuous cough or fever or anosmia," Van-Tam, who previously worked at SmithKline Beecham, Roche and Aventis Pasteur, told reporters today (May18).

For the purposes of public messaging, anosmia - the loss of smell - will be defined as a loss of smell and taste as the two are very closely linked in a neurological sense, Van-Tam said.

By adding anosmia the sensitivity of new case pick up could increase to 93 per cent from 91 per cent with just new cough and fever, Van-Tam said.

Other possible symptoms of COVID-19 include fatigue, diarrhoea, abdominal pain, or loss of appetite but have not been included in the basic case definition.

When asked why the United Kingdom has lagged other countries in including the loss of smell in its official list, Van-Tam said:

"The question is: Which of those symptoms actually make the interception of cases better or worse?"

Van-Tam said the government's New and Emerging Respiratory Virus Threats Advisory Group, or NERVTAG, had first looked at anosmia on March 27 but had kept it under review until a few days ago when the new advice was approved by the United Kingdom's top clinicians group.

NERVTAG ultimately decided that adding anosmia would increase the number of cases picked up after reviewing data on laboratory-confirmed cases. It relied on data from a Public Health England surveillance system known as the First Few 100, or FF100.

It also used comparisons from other data on respiratory viruses - primarily from University College London's Virus Watch study.

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less